Jane Liesveld is a Hematology physician affiliated with University of Rochester Medical Center. OpenAlex indexes 438 publications with 14,735 citations (h-index 63); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Box Med
Rochester, NY 146420001
Telephone
585-275-0784Registry record last updated 30 Jun 2023.
Clinical trials
- Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
Sponsor: University of Rochester
- Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
Sponsor: Jane Liesveld
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- National Marrow Donor ProgramProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2026$534,854R01AG079556 - Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2025$524,156R01AG079556 - Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2024$534,854R01AG079556
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Paul Barr, MD
University of Rochester Medical Center
Christopher Ritchlin, MD
University of Rochester Medical Center
Joseph Antin, MD
Boston University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”